ISSN Print 2500–1094
ISSN Online 2542–1204
BIOMEDICAL JOURNAL OF PIROGOV UNIVERSITY (MOSCOW, RUSSIA)
Copyright: © 2025 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
ORIGINAL RESEARCH
Monitoring the spread of COVID-19 across tuberculosis patients in Moscow
About authors
Moscow Research and Clinical Center for Tuberculosis Control of the Moscow Government Department of Health, Moscow, Russia
Correspondence should be addressed: Elena V. Sumarokova
Stromynka, 10, Moscow, 107014, Russia; ur.som.vardz@1VEavokoramus
About paper
Author contribution: Kotova EA, Belilovsky EM — developing the method, literature review, manuscript writing, editing; Sumarokova EV — data acquisition and analysis, developing the method, literature review, manuscript writing, editing; Monchakovskaya ES — statistical data processing.
Compliance with ethical standards: retrospective processing of the registry data did not involve personal information
Received: 2024-11-12
Accepted: 2025-01-15
Published online: 2025-02-11
|
Fig. 1. Age dependence of new tuberculosis cases and tuberculosis relapses depending on the fact of COVID-19 detection (Moscow, 2020–2023)
Fig. 2. Factors associated with the presence of COVID-19 in tuberculosis patients, univariate (A) and multivariate (B) analysis. Odds ratio (OR) of detecting COVID-19 co-infection in the presence of this symptom in a tuberculosis patient or the relationship between this symptom and the fact of having COVID-19 (Moscow, 2020–2023)
Fig. 3. Results of monitoring the course of COVID-19 in 1837 patients with TB combined with COVID-19, who were admitted for treatment for the first time in 2020–2023 in Moscow. Severe cases also include extremely severe COVID-19 (ARDS or pneumonia with ARF and the need for mechanical ventilation)
Table 1. Methods to detect and diagnose COVID-19 in tuberculosis patients with confirmed coronavirus infection admitted for treatment for the first time (Moscow, 2020–2023)*
Note: * — No information was available for 35 patients.
Table 2. Factors associated with the fact of having COVID-19 in new tuberculosis cases and relapses of tuberculosis (Moscow, 2020–2023). Univaruate and multivariate analysis
Note: group 1 — TB/COVID-19 patients, group 2 — newly diagnosed patients with tuberculosis and relapses of tuberculosis that have not been added to the TB/COVID-19 registry. PTB — pulmonary tuberculosis, CAD — coronary artery disease, COPD — chronic non-specific lung diseases.
Table 3. Results of immunoglobulin IgM and IgG tests obtained when detecting COVID-19 in patients with tuberculosis (Moscow, 2020–2023)
Note: * — no more than 7 days have passed since the infection; * * — acute infection, infection history 1–3 weeks. * * * — infection history 3–10 weeks; * * * * — body’s exposure to the virus took place more than 10–12 weeks ago.
